Category Archives: Muscular Dystrophy Treatment

As the death toll from the novel coronavirus climbs toward 90,000, a new national survey shows that a majority of Americans believe that the U.S. government should regulate the profits drug companies can make from drugs that treat or prevent Covid-19. Although the pharmaceutical industrys pricing practices have come under increasing scrutiny in the past few years, Covid-19 seems to be galvanizing public opinion in a way that should make any drug company executive or investor who is imagining fat profits for its Covid-19 therapies of vaccines think again Continue reading →

Trying to hack fitness is a multi-million-dollar industry; weve all seen at least one ad featuring a purported miracle product that claims it can make people lose weight and look greatwithout even trying. Continue reading →

People who are overweight and suffering from joint pain caused by osteoarthritis are often reluctant to exercise, even though physical activity can boost muscle strength and relieve pain. A new study suggests gene therapy may someday be a good option for those peopleand it may help them shed pounds, too. Continue reading →

Pharmacia & Upjohn LLC Duchenne Muscular Dystrophy Treatment Market Competitive Analysis: Consistent technological developments, surging industrialization, raw material affluence, increasing demand for the Duchenne Muscular Dystrophy Treatment , and rising disposable incomes, soaring product awareness are adding considerable revenue to the market. According to the report, the Duchenne Muscular Dystrophy Treatment market is expected to report a healthy CAGR from 2020 to 2026 Continue reading →

Bacterial vaginosis (BV), an inflammatory condition caused by the proliferation of bad bacteria naturally found in the vagina, can affect up to half the women of reproductive age worldwide. Continue reading →

May 16, 2020 | 3:34 p.m. Continue reading →

Moncef Slaoui stepped off Modernas board of directors on Friday and pivoted straight into the high profile role heading the Trump administrations Project Warp Speed, where hell be in charge of accelerating Modernas and others vaccines to a rapid release for a pandemic weary world. The news became official mid-day Friday after numerous reports earlier that he had been picked off the short list of candidates Continue reading →

In a few days, through a series of video conferences, gene therapy researchers around the world will be presenting their latest findings at the virtual annual meeting of the American Society of Gene & Cell Therapy. Almost every discussion will feature a topic that has been central to the existence of the field but continues to perplex experts as they seek to refine the modality: the delivery of a gene to the tissue where its needed to fix disease. For the first time, a biotech upstart will be publicly outlining their take on the problem with an artificial intelligence flavor that Novartis and Sarepta are gobbling up. Continue reading →

In wide-ranging congressional testimony, the ousted head of an agency at the center of the federal governments Covid-19 vaccine and treatment response criticized the Trump administration for a slow-footed federal response that could resound throughout the course of the pandemic. I believe we could have done better, Rick Bright, former chief of the Biomedical Advanced Research and Development Authority (BARDA), told a House subcommittee. We dont have the right leadership for this response and we dont have the right plan for this response Continue reading →

May 11, 2020 09:00 ET | Source: CRISPR Therapeutics AG ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, May 11, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX001, an investigational, autologous, gene-edited hematopoietic stem cell therapy, for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) Continue reading →